Sanofi Income Tax Expense Continuing Operations
Sanofi (SNY) reported Income Tax Expense Continuing Operations of EUR 1.04 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2026-02-17
| Period end | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 6 month as first filed | Income Tax Expense Continuing Operations 12 month | Income Tax Expense Continuing Operations 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 1.04B EUR 20-F · filed 2026-02-17 | |||
| 2025-06-30 | 711.00M EUR 6-K · filed 2025-10-27 | |||
| 2024-12-31 | 1.20B EUR 20-F · filed 2026-02-17 | |||
| 2024-06-30 | 379.00M EUR 6-K · filed 2025-10-27 | 463.00M EUR 6-K · filed 2024-07-25 | ||
| 2023-12-31 | 1.02B EUR 20-F · filed 2026-02-17 | 1.60B EUR 20-F · filed 2024-02-23 | ||
| 2023-06-30 | 730.00M EUR 6-K · filed 2024-07-25 | |||
| 2022-12-31 | 1.91B EUR 20-F · filed 2025-02-13 | 2.01B EUR 20-F · filed 2023-02-24 | ||
| 2022-06-30 | 495.00M EUR 6-K · filed 2023-07-28 | |||
| 2021-12-31 | 1.56B EUR 20-F · filed 2024-02-23 | |||
| 2021-06-30 | 678.00M EUR 6-K · filed 2022-07-28 | 682.00M EUR 6-K · filed 2021-07-29 | ||
| 2020-12-31 | 1.81B EUR 20-F · filed 2023-02-24 | 1.81B EUR 20-F · filed 2021-03-04 | ||
| 2020-06-30 | 994.00M EUR 6-K · filed 2021-07-29 | |||
| 2019-12-31 | 121.00M EUR 20-F · filed 2022-02-23 | 139.00M EUR 20-F · filed 2020-03-05 | ||
| 2019-06-30 | 13.00M EUR 6-K · filed 2020-07-29 | |||
| 2018-12-31 | 481.00M EUR 20-F · filed 2021-03-04 | |||
| 2017-12-31 | 1.72B EUR 20-F · filed 2020-03-05 | |||
| 2016-12-31 | 1.32B EUR 20-F · filed 2019-03-08 | 1.33B EUR 20-F/A · filed 2018-03-16 | ||
| 2015-12-31 | 709.00M EUR 20-F/A · filed 2018-03-16 |